3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Ovarian Neoplasms
17
Peritoneal Neoplasms
13
Fallopian Tube Neoplasms
10
Colorectal Neoplasms
8
Stomach Neoplasms
5
Carcinoma, Ovarian Epithelial
5
Hyperthermia
3
Gastrointestinal Neoplasms
3
Appendiceal Neoplasms
3
Adrenocortical Carcinoma
3
Sarcoma
2
Rhabdomyosarcoma
2
Neoplasms
2
Mesothelioma, Malignant
2
Mesothelioma
2
Glioma
2
Glioblastoma
2
Desmoplastic Small Round Cell Tumor
2
Colonic Neoplasms
2
Carcinoma
2
Brain Neoplasms
2
Adenoma, Islet Cell
2
Wilms Tumor
1
Retroperitoneal Neoplasms
1
Recurrence
1
Rectal Neoplasms
1
Pseudomyxoma Peritonei
1
Pleural Effusion, Malignant
1
Peritoneal Cavity Cancer
1
Pelvic Neoplasms
1
Interventions
Specimen Handling
2
Radiotherapy
2
Iohexol
2
Gemcitabine
2
spartalizumab
1
sodium thiosulfate
1
liposomal doxorubicin
1
X-Rays
1
Vorinostat
1
Surgical Procedures, Operative
1
Sunitinib
1
Solutions
1
Saline Solution
1
Re-Irradiation
1
Radiotherapy, Image-Guided
1
Radiosurgery
1
Probiotics
1
Platinum
1
Particle Accelerators
1
Pafolacianine
1
Paclitaxel
1
Magnetic Resonance Spectroscopy
1
Magnetic Resonance Imaging
1
Lidocaine
1
Ketamine
1
Injections
1
Immunotherapy, Adoptive
1
Hyperthermic Intraperitoneal Chemotherapy
1
FS 069
1
Embolization, Therapeutic
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Pelvic Neoplasms
×
Cytoreduction Surgical Procedures
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled